Abbott Laboratories (ABT)

Payables turnover

		Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Cost of revenue (ttm)	US$ in thousands	18,630,000	18,671,000	18,578,000	18,491,000	18,385,000	17,995,000	18,019,000	18,469,000	19,142,000	19,315,000	19,109,000	19,123,000	18,537,000	18,264,000	17,807,000	16,123,000	15,003,000	13,944,000	13,336,000	13,352,000
Payables	US$ in thousands	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Payables turnover		—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

December 31, 2024 calculation

Payables turnover = Cost of revenue (ttm) ÷ Payables
= $18,630,000K ÷ $—K
= —

The payables turnover ratio for Abbott Laboratories is not available for the periods presented in the data. This ratio is typically used to evaluate how efficiently a company is managing its accounts payable in relation to its purchases. Without the specific figures for payables and cost of goods sold, we are unable to calculate or analyze the trend of this important financial metric for Abbott Laboratories. It is important for investors and stakeholders to monitor this ratio over time to assess the company's liquidity and relationship with its suppliers.